The action of sympatholytic drugs in experimental intestinal paralysis.
D000758:Anesthesia; D000818:Animals; D002415:Cats; D002746:Chlorpromazine / Q000494:pharmacology; D004195:Disease Models, Animal; D005730:Ganglionic Blockers / Q000494:pharmacology; D005769:Gastrointestinal Motility / Q000187:drug effects; D006591:Hexobarbital; D007415:Intestinal Obstruction / Q000139:chemically induced*; D007418:Intestinal Pseudo-Obstruction / Q000139:chemically induced; D010277:Parasympathomimetics / Q000494:pharmacology; D010634:Phenobarbital; D011183:Postoperative Complications; D013564:Sympathetic Nervous System / Q000473:pathology; D013565:Sympatholytics / Q000627:therapeutic use*; D014149:Tranquilizing Agents / Q000494:pharmacology; D014272:Trifluperidol / Q000494:pharmacology
D005730:Ganglionic Blockers; D010277:Parasympathomimetics; D013565:Sympatholytics; D014149:Tranquilizing Agents; D006591:Hexobarbital; D014272:Trifluperidol; D002746:Chlorpromazine; D010634:Phenobarbital